Results 301 to 302 of about 326,057 (302)
Some of the next articles are maybe not open access.

Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Journal of Oncology Pharmacy Practice, 2018
exaly  

Tyrosine kinase inhibitor induced pancreatitis

Journal of Oncology Pharmacy Practice, 2013
exaly  
diseases of the blood and blood-forming organs
neoplasms
tumors
oncology
including cancer and carcinogens
therapeutics
pharmacology
tyrosine kinase inhibitors
tyrosine kinase
previous   29  30  31  

Home - About - Disclaimer - Privacy